BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6741200)

  • 1. [4 weeks' administration of omeprazole: effect on acid behavior and basal hormone levels].
    Müller P; Seitz HK; Simon B; Dammann HG; Feurle G; Huefner M; Lichtwald K; Schmidt-Gayk H
    Z Gastroenterol; 1984 May; 22(5):236-40. PubMed ID: 6741200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG; Müller P; Seitz HK; Simon B
    Schweiz Med Wochenschr; 1983 Jun; 113(24):895-8. PubMed ID: 6348940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of omeprazole on insulin induced gastric secretion in man.
    Utley RJ; Wright R; Beastall GH; Carter DC
    Scott Med J; 1985 Apr; 30(2):96-100. PubMed ID: 3892679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP; Tuynman HA; Défize J; Pals G; Frants RR; Straub JP; Meuwissen SG
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Administration of ranitidine once in the evening for several weeks: effect on acidity and basal hormone levels in normal subjects].
    Müller P; Dammann HG; Simon B
    Arzneimittelforschung; 1985; 35(9):1472-4. PubMed ID: 3910054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels.
    Festen HP; Thijs JC; Lamers CB; Jansen JM; Pals G; Frants RR; Défize J; Meuwissen SG
    Gastroenterology; 1984 Nov; 87(5):1030-4. PubMed ID: 6479529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pantoprazole versus omeprazole: influence on meal-stimulated gastric acid secretion.
    Dammann HG; Burkhardt F
    Eur J Gastroenterol Hepatol; 1999 Nov; 11(11):1277-82. PubMed ID: 10563540
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of 'weekend therapy' with omeprazole on basal and stimulated acid secretion and fasting plasma gastrin in duodenal ulcer patients.
    Hewson EG; Yeomans ND; Angus PW; Shulkes A; Brook CW; Sewell RB; Smallwood RA
    Gut; 1988 Dec; 29(12):1715-20. PubMed ID: 3220312
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship of omeprazole-induced hypergastrinemia to gastric pH.
    Larson GM; Sullivan HW; Rayford PL
    Surgery; 1986 Aug; 100(2):175-80. PubMed ID: 3738749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Acid secretion inhibition with new mechanisms of action: substituted benzimidazole].
    Olbe L; Lind T; Carlsson E; Cederberg C; Helander H; Wallmark B
    Schweiz Med Wochenschr; 1984 May; 114(20):683-5. PubMed ID: 6740286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of omeprazole on gastric acid secretion in man.
    Olbe L; Lind T; Cederberg C; Ekenved G
    Scand J Gastroenterol Suppl; 1986; 118():105-7. PubMed ID: 3460164
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of omeprazole in duodenal ulcer patients.
    Karvonen AL; Keyriläinen O; Uusitalo A; Salaspuro M; Tarpila S; Andrén K; Helander HF
    Scand J Gastroenterol; 1986 May; 21(4):449-54. PubMed ID: 3523740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response study of omeprazole on meal-stimulated gastric acid secretion and gastrin release.
    Londong W; Londong V; Cederberg C; Steffen H
    Gastroenterology; 1983 Dec; 85(6):1373-8. PubMed ID: 6354828
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P; Seitz HK; Simon B; Dammann HG
    Arzneimittelforschung; 1983; 33(12):1685-6. PubMed ID: 6686775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW; Forrest JA; Reid JL
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human gastric acid secretion following repeated doses of AG-1749.
    Müller P; Dammann HG; Leucht U; Simon B
    Aliment Pharmacol Ther; 1989 Apr; 3(2):193-8. PubMed ID: 2491469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA; Boyd EJ; Wormsley KG
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
    Clissold SP; Campoli-Richards DM
    Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.
    Kittang E; Aadland E; Schjønsby H
    Gut; 1985 Jun; 26(6):594-8. PubMed ID: 3924748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of IY-81149, a newly developed proton pump inhibitor, on gastric acid secretion in vitro and in vivo.
    Kwon D; Chae JB; Park CW; Kim YS; Lee SM; Kim EJ; Huh IH; Kim DY; Cho KD
    Arzneimittelforschung; 2001; 51(3):204-13. PubMed ID: 11304936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.